¶ÔôÇ»ù±½¸Ê°±Ëá,p-HydroxyphenylglycineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±£³ÖÂÊ,retentionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë¥ÍËÆÚ,FadingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ⱦ¶¾,poisoningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶þÇâÈôµ¤Ã÷,DihydrorhodamineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÛÍ´¸ÐÊÜÆ÷,NociceptorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á÷µ÷ÖÐÐÄÓÃÒÖÓôÁ¿±í,CES-DÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔ°×ÖÊÏ¡ÊèÖ¢,LeukoaraiosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Rnd1µ°°×,Rnd1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾Ö²¿ÄÔѪÁ÷¹à×¢,regional cerebral blood flowÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶÷±ØÆÕÈí½ºÄÒ,dl-3-butylphthalideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÃÒ©Çé¿ö,MedicationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÀàȱѪÔÙ¹à×¢,ischemia-like-reperfusionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¹Ìå½áºÏ,complement-bindingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÒÐý×ôÆ¥¿Ë¡,S-ZopicloneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á×ËữRb,Phospho-RbÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ê״η¢×÷,First-episodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÇÌÇÄò²¡ÐÔ,Non-diabeticÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µç³é´¤ÖÎÁÆ,ECTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Beclin1»ùÒò,Beclin1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÂѪ¹ÜÐγÉ,neovascularizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¬Ñõ»¯ÎïÆ绯ø1,SOD1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÈÄýÊõ,ThermocoagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔÈí»¯,EncephalomalaciaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ç¿ÆÈÕÏ°­,OCDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« TaqIA,PolymorphismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­³ÉÏñ,NeuroimagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¤ëÄÊÍ·ÅøÀà,KallikreinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±¶¯Âö¹Üǻֱ¾¶,CCADÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌåÍâ·¢Éú,EctogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÅÁÂÞÎ÷¶¡,paroxetineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ү³²¼ÀÊÇ¿ÆÈÁ¿±í,Y-BOCSÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±½¶þµªÀà,benzodiazepinesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °±¼ºÏ©Ëá,vigabatrinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« רע´ï,ConcertaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ëë×Ì춬ø-12,caspase-12Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¡µçͼ(EMG),Electromyogram(EMG)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´Å¹²Õñ¾²ÂöѪ¹Ü³ÉÏñ,MRVÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÁ´ïÀ­·î,edaravoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏËÈÜøԭ¼¤»îÒÖÖÆÎï,PAI-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÄÀ­·¨ÐÁ»ºÊͼÁ,venlafaxineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õò¾²Êõ,sedationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Çç¶û,OzagrelÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥¹â×Ó·¢Éä¶Ï²ãɨÃè,SPECTÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­ÐÂÉú,NeurogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÜѪÁ×Ö¬Àà,lysophospholipidsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶î,ForeheadÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µçÊÓ͸ÊÓ¼ì²é,VideofluoroscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃâÒßÓ¡¼£·´Ó¦,immunoblottingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙ×éÖ¯,ThymusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ƤÖÊ·¢ÓýÕÏ°­,disorders of cortical developmentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ˺ÍÑÊõ,avulsionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²©Ë¼Çå,BriskingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °Úλ,positioningÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ϣ˹Ãô,HismanalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ìå¸Ð,SomatosensoryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔ½ºÖÊϸ°ûÁö,GliomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÕØÊÂÕØ»ö,troublemakingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ñ²ðï/²¢·¢Ö¢,Epilepsy/complicationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¨Ìضû16ÖÖÈ˸ñÒòËØÁ¿±í,16PFÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Á¬½ÓËØ¿¹Ìå,Titin-AbÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾«ÉñÍâ¿Æ,PsychosurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Í´¾õÒì³£,allodyniaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌåÐÎÖ¸Êý,BMIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×¢Ò⹦ÄÜ,AttentionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ç¿Ö±ÕóÂÎÐÔ,tonic-clonicÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÔʵÖÊ,ParenchymaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ñ²ðï/²¡Òòѧ,Epilepsy/EtiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ÇÒäÉÌ,MQÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °±/ѪҺ,Ammonia/BloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ú²¿,earÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³£¹æÄÔµçͼ,REEGÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ƤÖʵçͼ,electrocorticogramÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂçÌ©,luotaiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²Ô°×ÇòÄڲಿ,GPiÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °±¶¡Èý´¼,tromethamineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʧд֢,AgraphiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÅÁÂÞÎ÷Í¡/ÖÎÁÆÓ¦ÓÃ,paroxetine/TUÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Rhoµ°°×,Rho proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« LDL/ѪҺ,LDL/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ù²è·ÓÁÚ¼×»ùתÒÆø,Catechol-O-methyltransferaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­½ºÖÊÁö/Õï¶Ï,glioma/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÐÄÔÖÜΧ·Ç¶¯ÂöÁöÐÔÖëÍøĤÏÂÇ»³öѪ,PNSHÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ç¿·ÈëÄÔ­,prodynorphinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÒ©ÄÍÒ©»ùÒò-1,mdr1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÒÅݵ¥°·×ªÔËÌå,VMAT2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄýѪ״̬,CoagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºÚÖÊÎÆ×´Ìå,nigrostriatumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶à¶¯,HyperactivityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ç⻯Âó½Ç¼î,dihydroergotoxineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËèÇÊÍÑʧ,DemyelinationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌåÄÚ΢͸Îö,MicrodialysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾«Éñ´´ÉË,spiritual traumaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÒõ£µ¨¼î(Ach),acetylcholineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʧд,AgraphiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹Èë׸ÊëÄÛÏ»ùתÒÆø,glutathione-S-transferaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­Ê³µÀ³¬Éù,echocardiographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖؾÆʯËῨ°ÍÀ­Í¡,RivastigmineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ÉÀ­Ã÷,CoramineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ñ²ý¢,EpilepsyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
 ÉÏÒ»Ò³ 1 2 3 4 5 6 7 8 ÉÏÒ»Ò³